Table 1.
Comparison of COVID-Negative Patients Presenting With ACS in 2019 and 2020
| Admissions 2019 (n = 26) | Admissions 2020 (n = 22) | p Value | ||
|---|---|---|---|---|
| Male | 32 (66.7) | 15 (57.7) | 17 (77.3) | 0.221 |
| Age, yrs | 71 ± 14 | 70.7 ± 15.9 | 72.6 ± 11.42 | 0.649 |
| Hypertension | 31 (64.6) | 20 (76.9) | 11 (50.0) | 0.072 |
| Diabetes | 12 (25) | 6 (23.1) | 6 (27.3) | 0.751 |
| Smoking | 11 (23) | 6 (23.1) | 5 (22.7) | 1.00 |
| Dyslipidemia | 18 (37.5) | 10 (38.5) | 8 (36.4) | 1.00 |
| Access by ambulance | 30 (62.5) | 12 (46.2) | 18 (81.8) | 0.017 |
| Pre-coronary time, h | 7 (3–12) | 7 (3.5–12.0) | 6 (3–12) | 0.786 |
| Symptoms onset to FMC, min | 241 (120–731) | 311 (188–649) | 216.5 (117.5–880.2) | 0.541 |
| ED arrival to diagnosis, min | 13.5 (8.0–37.5) | 9 (7–37) | 19 (11–41) | 0.087 |
| ED arrival to ED discharge, min | 33 (10–60) | 17 (7–46) | 40 (15.8–127.5) | 0.075 |
| ED discharge to cath-lab arrival, min | 39 (21–54) | 38 (18–54) | 41 (26.0–218.5) | 0.274 |
| Cath-lab arrival to wire crossing, min | 33 (26–40) | 31 (24–39) | 34 (27.8–43.8) | 0.291 |
| Symptoms onset to wire crossing, min | 495 (224–997) | 417 (245–820) | 525 (211.0–1,716.5) | 0.410 |
| ED admission to wire crossing, min | 105 (84–206) | 94 (84–136) | 196 (82–398) | 0.038∗ |
| Length of stay, days | 8 (6–13) | 7.5 (6–11) | 9.5 (6.0–14.3) | 0.395 |
| GRACE | 164 (140–188) | 173.5 (144.2; 192.5) | 160.2 (134–188) | 0.768 |
| In-hospital MACE | 7 (15.2) | 1 (3.8) | 6 (27.3) | 0.038∗ |
Values are n (%), mean ± SD, or median (interquartile range).
ACS = acute coronary syndromes; Cath-lab = catheterization laboratory; COVID = coronavirus disease; ED = emergency department; FMC = first medical contact; GRACE = Global Registry of Acute Coronary Events; MACE = major adverse cardiovascular events (including sustained ventricular arrhythmias, nonfatal stroke).
∗
p < 0.05.